India to Sri Lanka: Serum Export Trade Route

The India to Sri Lanka Serum corridor is one of India's established pharmaceutical export routes, with 41 shipments documented worth a combined $1.5M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED , which alone accounts for roughly 32% of all export value, reflecting the consolidated nature of India's serum manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $36.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 34.6%, placing it at rank #7 among India's top serum export destinations globally.

On the import side, key buyers of Indian serum in Sri Lanka include STATE PHARMACEUTICALS CORPORATION , STATE PHARMACEUTICALS CORPORATION O , SCPSC and 13 others. STATE PHARMACEUTICALS CORPORATION is the single largest importer with 2 shipments valued at $290.1K USD.

India's serum exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. BHARAT SERUMS AND VACCINES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED , VINS BIOPRODUCTS LIMITED , BHARAT SERUMS AND VACCINES LIMITED — together account for 79% of total trade value on this route. The average shipment value of $36.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as equirab 1000 iu/ 5ml [rabies antiserum-e and equirab 1000 iu 5ml rabies antiserum equine, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, STATE PHARMACEUTICALS CORPORATION is the largest importer with 2 shipments worth $290.1K USD — representing 20% of all serum imports from India on this route. A total of 16 buyers are active on this corridor.